Quasi-experimental Study With a Control Group to Evaluate a Psychoeducational Intervention in Parkinson's Disease Patients and Carers
ReNACE-PD01
1 other identifier
interventional
140
1 country
1
Brief Summary
The aim of this study is to evaluate the effects of a psychoeducational multidisciplinary intervention focusing on improving coping skills, the psychosocial adaptation to Parkinson's disease and the quality of life in patents and family carers in a Primary Care setting. On the basis of previous research, the hypothesis we propose is that through the development of coping skills which will contribute to promoting a positive psychosocial adaptation to Parkinson' disease, the quality of life of the people with Parkinson's disease and their family carers will be improved. At the same time, it is predicted that, by incorporating this psychoeducational intervention into clinical practice, the patients and family caregivers will perceive a greater sense of normality in their lives, which will also promote compliance with drug treatments and promote healthy lifestyles. In the long-term, such an approach could have positive effects on the overall health of patients and their family carers. This quasi-experimental study with control group and mixed methods was designed to evaluate the ReNACE psychoeducational intervention (ReNACE is the spanish acronym for the Research Programme and means Recovery, Normalisation, Acceptance and Living with Chronic illness). Based on the relevant study power calculations, 100 people with Parkinson's disease and 100 family carers will be recruited. Participants will be assigned to two groups. The intervention group will receive the ReNACE psychoeducational intervention. The control group will be given a general educational program. The study will be carried out in community-based health centers. The results obtained from the two groups will be evaluated at three time points: at baseline, immediately after the intervention and at 6 months after the intervention. The results will be measured with the following instruments: the Quality of Life Scale PDQ-39 (The 39-item Parkinson's Disease Questionnaire) for patients and the Quality of Life Scale for caregivers SQLC (Scale of Quality of Life of Caregivers) for family carers, and for patients and family carers the Psychosocial Adjustment to Illness Scale Self-report (PAIS-SR) and the Brief Cope Inventory. To determine the acceptability of the intervention, focus groups will be organized with some patients and family carers who have received the ReNACE intervention and also with the healthcare professionals involved in its development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Mar 2015
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 11, 2017
CompletedFirst Posted
Study publicly available on registry
April 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedSeptember 23, 2020
September 1, 2020
2.8 years
April 11, 2017
September 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline Quality of life at 9 weeks and 24 weeks (6 months) in patients with Parkinson's disease
The quality of life is measured by the PDQ-39 (the 39-item Parkinson's Disease Questionnaire)
Baseline, 9 weeks and 24 weeks
Change from Baseline Quality of life at 9 weeks and 24 weeks (6 months) in family carers
The quality of life is measured by the SQLC (Scale of Quality of Life of Caregivers)
Baseline, 9 weeks and 24 weeks
Secondary Outcomes (2)
Change from Baseline Coping at 9 weeks and 24 weeks (6 months)
Baseline, 9 weeks and 24 weeks
Change from Baseline Psychosocial adaptation to illness at 9 weeks and 24 weeks (6 months)
Baseline, 9 weeks and 24 weeks
Study Arms (2)
Intervention group
EXPERIMENTALSessions in groups
Control group
SHAM COMPARATORSessions in groups
Interventions
9 sessions in groups of 15-20 people at most so as to promote reflection and facilitate the interchange of opinions between participants about issues of interest from their day to day experience of coping with Parkinson's disease.
5 sessions in groups of 15-20 people
Eligibility Criteria
You may qualify if:
- People with Parkinson's disease receiving care as outpatients in the designated centers in any stage of the disease (as determined by a researcher with the Hoehn \& Yahr scale), residing at that time in Navarra, fluent in the speaking and understanding of the Spanish language, and with preserved cognitive ability.
- Family members/carers will be over the age of 18, living or maintaining a close relationship with a patient and actively collaborating in the care of the patient, currently residing in Navarra and fluent in the speaking and understanding of the Spanish language
You may not qualify if:
- People with Parkinson's disease and family members who do not wish to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Servicio Navarro de Salud-Osasunbidea
Pamplona, Navarre, Spain
Related Publications (1)
Navarta-Sanchez MV, Ursua ME, Riverol Fernandez M, Ambrosio L, Medina M, Diaz de Cerio S, Alvarez MJ, Senosiain JM, Gorraiz A, Caparros N, Anaut S, Martin-Lanas R, Recio M, Portillo MC. Implementation of a multidisciplinary psychoeducational intervention for Parkinson's disease patients and carers in the community: study protocol. BMC Fam Pract. 2018 Apr 5;19(1):45. doi: 10.1186/s12875-018-0730-9.
PMID: 29621985DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Francisco Javier Mata Rodríguez
Director Research Department (OTRI). University of Navarre.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2017
First Posted
April 26, 2017
Study Start
March 1, 2015
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
September 23, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share
Participant data from scales will not be shared with other researchers.